Your browser doesn't support javascript.
loading
Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5.
Tan, Chee-Wah; Lim, Beng-Lee; Young, Barnaby E; Yeoh, Aileen Ying-Yan; Yung, Chee-Fu; Yap, Wee-Chee; Althaus, Thomas; Chia, Wan-Ni; Zhu, Feng; Lye, David Chien; Wang, Lin-Fa.
Affiliation
  • Tan CW; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore. Electronic address: cheewah.tan@duke-nus.edu.sg.
  • Lim BL; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore.
  • Young BE; National Center for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore.
  • Yeoh AY; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore.
  • Yung CF; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore; Infectious Disease Service, Department of Pediatrics, KK Women's and Children's Hospital, Singapore; Duke-NUS Medical School, Singapore.
  • Yap WC; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore.
  • Althaus T; Centre Scientifique de Monaco, Monaco; Direction de I'Action Sanitaire de Monaco, Monaco.
  • Chia WN; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore.
  • Zhu F; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore.
  • Lye DC; National Center for Infectious Diseases, Singapore; Tan Tock Seng Hospital, Singapore; Lee Kong Chian School of Medicine, Nanyang Technology University, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Wang LF; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 169857, Singapore. Electronic address: linfa.wang@duke-nus.edu.sg.
Lancet Microbe ; 3(12): e898, 2022 12.
Article de En | MEDLINE | ID: mdl-35963276

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Humans Langue: En Journal: Lancet Microbe Année: 2022 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Limites: Humans Langue: En Journal: Lancet Microbe Année: 2022 Type de document: Article Pays de publication: Royaume-Uni